The World Health Organization said it has halted studies of
hydroxychloroquine in its Solidarity Trial after The Lancet published
a piece that said a higher mortality rate was estimated for critically
ill patients who received the drug, when used alone or with a
macrolide.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/who-calls-halt-to-solidarity-trial-of-hcq/articleshow/75990966.cms
No comments:
Post a Comment